NCTM Studio Legale Associato assisted Yarpa and LBO France, leading private equity funds in Europe, in the sale of the entire share capital of IZO S.r.l. to Vaxxinova GmbH, a German company producing and marketing autogenous vaccines for farmed animals, care for the animals and GMP certified contract manufacturing of veterinary vaccines and antigens.

IZO is an Italian veterinary company founded within the Institute Zooprofilattico of Lombardia and Emilia Romagna regions in 1968, and acquired by Yarpa and LBO France in 2012.

The agreement with Vaxxinova provides for the further development of the existing structures of IZO, in order to increase its growth as an international player in the vaccines and veterinary drugs markets.

NCTM has assisted Yarpa and LBO France, with a team led by Matteo Trapani, equity partner.